| Therapy | Drug | Total | |||
| Physician | Pharmacist | Patient | |||
| First-line therapy | Fosfomycin | 24.15% (n=7) |
3.45% (n=1) |
6.9% (n=2) |
55.2% (n=16) |
| Nitrofurantoin | 13.8% (n=4) |
3.45% (n=1) |
3.45% (n=1) |
||
| Second-line therapy | Amoxicillin clavulanate | 6.9% (n=2) |
0.0% (n=0) |
0.0% (n=0) |
6.9% (n=2) |
| Fluoroquinolones | Norfloxacin | 10.3% (n=3) |
0.0% (n=0) |
0.0% (n=0) |
10.3% (n=3) |
| Others Antibiotics | Co-trimoxazole | 6.9% (n=2) |
0.0% (n=0) |
0.0% (n=0) |
6.9% (n=2) |
| Others Therapies | Flavoxate | 3.45% (n=1) |
10.35% (n=3) |
0.0% (n=0) |
20.7% (n=6) |
| Trospium chloride | 3.45% (n=1) |
0.0% (n=0) |
0.0% (n=0) |
||
| Cranberry | 0.0% (n=0) |
3.45% (n=1) |
0.0% (n=0) |
||